2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
Open accessThe DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee (https://doi.org/10.2337/dc20-SPPC), a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Type 2 diabetes is characterized by insulin resistance driven by chronic hyperglycemia”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Self-citation(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Diagnosis and Classification of diabetes mellitus
(2014) · Diapedia · doi:10.14496/dia..20 · Cited by 3,214
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015) · JAMA · doi:10.1001/jama.2015.10029 · Cited by 2,362 · cited 1×
“The finding that one-third to onehalf of diabetes in Asian Americans is undiagnosed suggests that testing is not occurring at lower BMI thresholds (63,64).”
BackgroundGestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276 · cited 1×
“GDM is often indicative of underlying b-cell dysfunction (135), which confers marked increased risk for later development of diabetes, generally but not always type 2 diabetes, in the mother after delivery (136,137).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Glucose-6-phosphate dehydrogenase deficiency
Cappellini, M., & Fiorelli, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60073-2 · Cited by 1,590
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
(1964) · PubMed · Cited by 1,230
Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216 · cited 2×
“, relatives of those with type 1 diabetes or individuals from the general population with type 1 diabetes–associated genetic factors) identifies individuals who may develop type 1 diabetes (9).”
BackgroundRatner, R. E., Christophi, C. A., Metzger, B. E., Dabelea, D., Bennett, P. H., Pi-Sunyer, X., Fowler, S., Kahn, S. E., & The Diabetes Prevention Program Research Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0772 · Cited by 867
Differentiation of diabetes by pathophysiology, natural history, and prognosis
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes · doi:10.2337/db16-0806 · Cited by 823
Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes
Moran, A., Brunzell, C., Cohen, R. C., Katz, M., Marshall, B. C., Onady, G., Robinson, K. A., Sabadosa, K. A., Stecenko, A., Slovis, B., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1768 · Cited by 726
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725 · cited 1×
“For individuals with MODY, the treatment implications are considerable and warrant genetic testing (104,105).”
BackgroundCowie, C. C., Rust, K. F., Byrd-Holt, D. D., Gregg, E. W., Ford, E. S., Geiss, L. S., Bainbridge, K. E., & Fradkin, J. E. (2010) · Diabetes Care · doi:10.2337/dc09-1524 · Cited by 689
Sacks, D. A., Hadden, D. R., Maresh, M., Deerochanawong, C., Dyer, A. R., Metzger, B. E., Lowe, L. P., Coustan, D. R., Hod, M., Oats, J. J. N., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1641 · Cited by 687
Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality
Moran, A., Dunitz, J., Nathan, B., Saeed, A., Holme, B., & Thomas, W. (2009) · Diabetes Care · doi:10.2337/dc09-0586 · Cited by 648 · cited 2×
“CFRD mortality has significantly decreased over time, and the gap in mortality between cystic fibrosis patients with and without diabetes has considerably narrowed (81).”
BackgroundLowe, W. L., Scholtens, D. M., Lowe, L. P., Kuang, A., Nodzenski, M., Talbot, O., Catalano, P. M., Linder, B., Brickman, W. J., Clayton, P., et al. (2018) · JAMA · doi:10.1001/jama.2018.11628 · Cited by 591 · cited 1×
“4-fold higher risk of developing prediabetes and type 2 diabetes and had children with a higher risk of obesity and increased body fat, suggesting that the larger group of women identified by the one-step approach would benefit from increased screening for diabetes and prediabetes that would accompany a history of GDM…”
BackgroundHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563 · cited 1×
“, corticosteroids, atypical antipsychotics, and sodium–glucose cotransporter 2 inhibitors) (53,54).”
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532 · cited 11×
“No studies to date have established which noninsulin agents are safest or most efficacious in PTDM.”
BackgroundMethodInfluentialDiabetes, pancreatogenic diabetes, and pancreatic cancer
Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516
BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
Hsu, W. C., Araneta, M. R. G., Kanaya, A. M., Chiang, J. L., & Fujimoto, W. (2015) · Diabetes Care · doi:10.2337/dc14-2391 · Cited by 500 · cited 1×
“However, data suggest that the BMI cut point should be lower for the Asian American population (60,61).”
BackgroundAroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3761 · Cited by 467
Griffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60698-3 · Cited by 462 · cited 1×
“A large European randomized controlled trial compared the impact of screening for diabetes and intensive multifactorial intervention with that of screening and routine care (55).”
BackgroundA1C level and future risk of diabetes: a systematic review
Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L. (2010) · Diabetes Care · doi:10.2337/dc09-1939 · Cited by 422 · cited 2×
“Similar to glucose measurements, the continuum of risk is curvilinear, so as A1C rises, the diabetes risk rises disproportionately (49).”
BackgroundBuchanan, T. A., Xiang, A., Kjos, S. L., & Watanabe, R. (2007) · Diabetes Care · doi:10.2337/dc07-s201 · Cited by 417
Wang, C., Wei, Y., Zhang, X., Zhang, Y., Xu, Q., Sun, Y., Su, S., Zhang, L., Liu, C., Feng, Y., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.037 · Cited by 416 · cited 1×
“As effective prevention interventions are available (138,139), women diagnosed with GDM should receive lifelong screening for prediabetes to allow interventions to reduce diabetes risk and for type 2 diabetes to allow treatment at the earliest possible time (140).”
BackgroundWheeler, E., Leong, A., Liu, C.-T., Hivert, M.-F., Strawbridge, R. J., Podmore, C., Li, M., Yao, J., Sim, X., Hong, J., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002383 · Cited by 408
Deriving ethnic-specific BMI cutoff points for assessing diabetes risk.
Chiu, M., Austin, P. C., Manuel, D. G., Shah, B. R., & Tu, J. V. (2011) · Diabetes Care · doi:10.2337/dc10-2300 · Cited by 398 · cited 7×
“African Americans heterozygous for the common hemoglobin variant HbS may have, for any given level of mean glycemia, lower A1C by about 0.3% than those without the trait (20).”
InfluentialPihoker, C., Gilliam, L. K., Ellard, S., Dabelea, D., Davis, C., Dolan, L. M., Greenbaum, C. J., Imperatore, G., Lawrence, J. M., Marcovina, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1279 · Cited by 397
In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring
Tam, W. H., Ma, R. C. W., Ozaki, R., Li, A. M., Chan, M. H. M., Yuen, L. Y., Lao, T. T. H., Yang, X., Ho, C. S., Tutino, G. E., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2397 · Cited by 366
Horvath, K., Koch, K., Jeitler, K., Matyas, E., Bender, R., Bastian, H., Lange, S., & Siebenhofer, A. (2010) · BMJ · doi:10.1136/bmj.c1395 · Cited by 359 · cited 1×
“gestational-age births (153), and shoulder”
De Franco, E., Flanagan, S. E., Houghton, J. A., Allen, H. L., Mackay, D. J., Temple, I. K., Ellard, S., & Hattersley, A. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60098-8 · Cited by 349
Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care · doi:10.2337/dci18-0052 · Cited by 349
Feig, D. S., Hwee, J., Shah, B. R., Booth, G. L., Bierman, A. S., & Lipscombe, L. L. (2014) · Diabetes Care · doi:10.2337/dc13-2717 · Cited by 346
Herman, W. H., Ye, W., Griffin, S. J., Simmons, R. K., Davies, M. J., Khunti, K., Rutten, G. E. H. M., Sandbaek, A., Lauritzen, T., Borch-Johnsen, K., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2459 · Cited by 340 · cited 1×
“Computer simulation modeling studies suggest that major benefits are likely to accrue from the early diagnosis and treatment of hyperglycemia and cardiovascular risk factors in type 2 diabetes (58); moreover, screening, beginning at age 30 or 45 years and independent of risk factors, may be cost-effective (,$11,000 pe…”
BackgroundDuran, A., Sáenz, S., Torrejón, M. J., Bordiú, E., del Valle, L., Galindo, M., Perez, N., Herraiz, M. A., Izquierdo, N., Rubio, M. A., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0179 · Cited by 335
Schwartz, S. S., Epstein, S., Corkey, B. E., Grant, S. F. A., Gavin, J. R., & Aguilar, R. B. (2016) · Diabetes Care · doi:10.2337/dc15-1585 · Cited by 329
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328 · cited 1×
“Several terms are used in the literature to describe the presence of diabetes following organ transplantation (85).”
BackgroundZiemer, D. C., Kolm, P., Weintraub, W. S., Vaccarino, V., Rhee, M. K., Twombly, J. G., Narayan, K. M. V., Koch, D. D., & Phillips, L. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-12-201006150-00004 · Cited by 326
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2596 · Cited by 306
Kahn, R., Alperin, P., Eddy, D., Borch-Johnsen, K., Buse, J., Feigelman, J., Gregg, E., Holman, R. R., Kirkman, M. S., Stern, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62162-0 · Cited by 287 · cited 1×
“Computer simulation modeling studies suggest that major benefits are likely to accrue from the early diagnosis and treatment of hyperglycemia and cardiovascular risk factors in type 2 diabetes (58); moreover, screening, beginning at age 30 or 45 years and independent of risk factors, may be cost-effective (,$11,000 pe…”
BackgroundWoodmansey, C., McGovern, A. P., McCullough, K. A., Whyte, M. B., Munro, N. M., Correa, A. C., Gatenby, P. A. C., Jones, S. A., & de Lusignan, S. (2017) · Diabetes Care · doi:10.2337/dc17-0542 · Cited by 280
(2013) · PubMed · Cited by 279
Adult-onset autoimmune diabetes: current knowledge and implications for management
Buzzetti, R., Zampetti, S., & Maddaloni, E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.99 · Cited by 271
(2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.08.002 · Cited by 268
Orban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0934 · Cited by 260
The diagnosis and management of monogenic diabetes in children and adolescents
Hattersley, A., Bruining, J., Shield, J., Njolstad, P., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00571.x · Cited by 255
Mild gestational diabetes mellitus and long-term child health
Landon, M. B., Rice, M. M., Varner, M. W., Casey, B. M., Reddy, U. M., Wapner, R. J., Rouse, D. J., Biggio, J. R., Thorp, J. M., Chien, E. K., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2159 · Cited by 248
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System
Fadini, G. P., Bonora, B. M., & Avogaro, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4301-8 · Cited by 242 · cited 1×
“, corticosteroids, atypical antipsychotics, and sodium–glucose cotransporter 2 inhibitors) (53,54).”
Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus: Clinical and Biochemical Differences
Newton, C. A., & Raskin, P. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.17.1925 · Cited by 237 · cited 1×
“Occasionally, patients with type 2 diabetes may present with DKA (6), particularly ethnic minorities (7).”
BackgroundShepherd, M., Shields, B., Hammersley, S., Hudson, M., McDonald, T. J., Colclough, K., Oram, R. A., Knight, B., Hyde, C., Cox, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0645 · Cited by 236
Kim, C., Bullard, K. M., Herman, W. H., & Beckles, G. L. (2010) · Diabetes Care · doi:10.2337/dc09-0836 · Cited by 213 · cited 1×
“A1C is less reliable than blood glucose measurement in other conditions such as the postpartum state (34–36), HIV treated with certain drugs (17), and iron-deficient anemia (37).”
BackgroundHerman, W. H., Dungan, K. M., Wolffenbuttel, B. H. R., Buse, J. B., Fahrbach, J. L., Jiang, H., & Martin, S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1940 · Cited by 210
Welsh, K. J., Kirkman, M. S., & Sacks, D. B. (2016) · Diabetes Care · doi:10.2337/dc15-2727 · Cited by 207
Racial differences in glycemic markers: a cross-sectional analysis of community-based data
Selvin, E., Steffes, M. W., Ballantyne, C. M., Hoogeveen, R. C., Coresh, J., & Brancati, F. L. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-5-201103010-00004 · Cited by 196 · cited 1×
“Though conflicting data exists, African Americans may also have higher levels of fructosamine and glycated albumin and lower levels of 1,5-anhydroglucitol, suggesting that their glycemic burden (particularly postprandially) may be higher (27,28).”
BackgroundThe hereditary pancreatitis gene maps to long arm of chromosome 7
Le Bodic, L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.549 · Cited by 196
The diagnosis and management of monogenic diabetes in children and adolescents
Rubio-Cabezas, O., Hattersley, A. T., Njølstad, P. R., Mlynarski, W., Ellard, S., White, N., Chi, D. V., & Craig, M. E. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12192 · Cited by 196
Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy
Schaefer, U. M., Songster, G., Xiang, A., Berkowitz, K., Buchanan, T. A., & Kjos, S. L. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70035-8 · Cited by 195 · cited 1×
“A compelling argument for further work in this area is the fact that hyperglycemia that would be diagnostic of diabetes outside of pregnancy and is present at the time of conception is associated with an increased risk of congenital malformations that is not seen with lower glucose levels (127,128).”
BackgroundIs pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed?
Hardt, P. D., Brendel, M. D., Kloer, H. U., & Bretzel, R. G. (2008) · Diabetes Care · doi:10.2337/dc08-s244 · Cited by 194
Identification of unrecognized diabetes and pre-diabetes in a dental setting
Lalla, E., Kunzel, C., Burkett, S., Cheng, B., & Lamster, I. B. (2011) · Journal of Dental Research · doi:10.1177/0022034511407069 · Cited by 193
Steck, A. K., Vehik, K., Bonifacio, E., Lernmark, A., Ziegler, A.-G., Hagopian, W. A., She, J., Simell, O., Akolkar, B., Krischer, J., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2426 · Cited by 185
Thomas, N. J., Lynam, A. L., Hill, A. V., Weedon, M. N., Shields, B. M., Oram, R. A., McDonald, T. J., Hattersley, A. T., & Jones, A. G. (2019) · Diabetologia · doi:10.1007/s00125-019-4863-8 · Cited by 183
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Issues with the diagnosis and classification of hyperglycemia in early pregnancy
McIntyre, H. D., Sacks, D. A., Barbour, L. A., Feig, D. S., Catalano, P. M., Damm, P., & McElduff, A. (2016) · Diabetes Care · doi:10.2337/dc15-1887 · Cited by 181 · cited 1×
“diagnosticcriteria for the75-gOGTTaswell as the GDM screening and diagnostic criteria used in the two-step approach were not derived from data in the first half of pregnancy, so the diagnosis of GDM in early pregnancy by either FPG or OGTT values is not evidence based (134) and further work is needed.”
MethodZhong, V. W., Juhaeri, J., & Mayer-Davis, E. J. (2018) · Diabetes Care · doi:10.2337/dc17-1583 · Cited by 177 · cited 11×
“Patients with type 1 diabetes often present with acute symptoms of diabetes and markedly elevated blood glucose levels, and approximately one-third are diagnosed with life-threatening DKA (2).”
BackgroundInfluentialMoran, A., Pillay, K., Becker, D., Granados, A., Hameed, S., & Acerini, C. L. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12732 · Cited by 171 · cited 1×
“Cystic fibrosis–related diabetes (CFRD) is the most common comorbidity in people with cystic fibrosis, occurring in about 20% of adolescents and 40–50% of adults (76).”
BackgroundShields, B. M., Shepherd, M., Hudson, M., McDonald, T. J., Colclough, K., Peters, J., Knight, B., Hyde, C., Ellard, S., Pearson, E. R., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0224 · Cited by 151
A1C underestimates glycemia in HIV infection
Kim, P. S., Woods, C., Georgoff, P., Crum, D., Rosenberg, A., Smith, M., & Hadigan, C. (2009) · Diabetes Care · doi:10.2337/dc09-0177 · Cited by 145 · cited 1×
“When using A1C to diagnose diabetes, it is important to recognize that A1C is an indirect measure of average blood glucose levels and to take other factors into consideration that may impact hemoglobin glycation independently of glycemia, such as hemodialysis, pregnancy, HIV treatment (17,18), age, race/ ethnicity, pr…”
MethodUtility of Glycated Hemoglobin in Diagnosing Type 2 Diabetes Mellitus: A Community-Based Study
Kumar, P. R., Bhansali, A., Ravikiran, M., Bhansali, S., Dutta, P., Thakur, J. S., Sachdeva, N., Bhadada, S. K., & Walia, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2433 · Cited by 145
The pharmacokinetics of pioglitazone in patients with impaired renal function
Budde, K., Neumayer, H., Fritsche, L., Sulowicz, W., Stompôr, T., & Eckland, D. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01785.x · Cited by 143 · cited 1×
“Thiazolidinediones have been used successfully in patients with liver andkidney transplants, but side effects include fluid retention, heart failure, and osteopenia (98,99).”
BackgroundAssociation of Sickle Cell Trait With Hemoglobin A1c in African Americans
Lacy, M. E., Wellenius, G. A., Sumner, A. E., Correa, A., Carnethon, M. R., Liem, R. I., Wilson, J. G., Sacks, D. B., Jacobs, D. R., Carson, A. P., et al. (2017) · JAMA · doi:10.1001/jama.2016.21035 · Cited by 141
Diabetes Prevention Program Research Group (2015) · Diabetes Care · doi:10.2337/dc14-0886 · Cited by 139
Rosenn, B., Miodovnik, M., Combs, C. A., Khoury, J. C., & Siddiqi, T. A. (1994) · PubMed · Cited by 136
Naylor, R. N., John, P. M., Winn, A. N., Carmody, D., Greeley, S. A. W., Philipson, L. H., Bell, G. I., & Huang, E. S. (2014) · Diabetes Care · doi:10.2337/dc13-0410 · Cited by 134 · cited 1×
“enables a cost-effective (112), often Table 2.”
Peterson, C., Grosse, S. D., Li, R., Sharma, A. J., Razzaghi, H., Herman, W. H., & Gilboa, S. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.09.009 · Cited by 130
Donovan, L., Hartling, L., Muise, M., Guthrie, A., Vandermeer, B., & Dryden, D. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00657 · Cited by 125
Hyperglycemia during the immediate period after kidney transplantation
Chakkera, H. A., Weil, E. J., Castro, J., Heilman, R. L., Reddy, K. S., Mazur, M. J., Hamawi, K., Mulligan, D. C., Moss, A. A., Mekeel, K. L., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05471008 · Cited by 124 · cited 1×
“In most cases, such stress- or steroidinduced hyperglycemia resolves by the time of discharge (89,90).”
BackgroundSosenko, J. M., Skyler, J. S., Palmer, J. P., Krischer, J. P., Yu, L., Mahon, J., Beam, C. A., Boulware, D. C., Rafkin, L., Schatz, D., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0425 · Cited by 123
Mayo, K., Melamed, N., Vandenberghe, H., & Berger, H. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.08.027 · Cited by 122 · cited 1×
“In addition, pregnancies complicated by GDM per the IADPSG criteria, but not recognized as such, have outcomes comparable to pregnancies with diagnosed GDM by the morestringent two-stepcriteria (161,162).”
BackgroundGlucose Metabolism After Renal Transplantation
Hecking, M., Kainz, A., Werzowa, J., Haidinger, M., Döller, D., Tura, A., Karaboyas, A., Hörl, W. H., Wolzt, M., Sharif, A., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2441 · Cited by 122
Hemoglobin A1c Versus Oral Glucose Tolerance Test in Postpartum Diabetes Screening
Picón, M. J., Murri, M., Muñoz, A., Fernández-García, J. C., Gomez-Huelgas, R., & Tinahones, F. J. (2012) · Diabetes Care · doi:10.2337/dc11-2111 · Cited by 122
Brown, F. M., & Wyckoff, J. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0922-z · Cited by 122
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Hecking, M., Werzowa, J., Haidinger, M., Horl, W. H., Pascual, J., Budde, K., Luan, F. L., Ojo, A., de Vries, A. P. J., Porrini, E., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs583 · Cited by 120
Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment
Greeley, S. A. W., Naylor, R. N., Philipson, L. H., & Bell, G. I. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0234-7 · Cited by 115 · cited 1×
“c Diabetes diagnosed within the first 6 months of life (with occasional cases presenting later, mostly INS and ABCC8 mutations) (103,116) c Diabetes without typical features of type 1 or type 2 diabetes (negative diabetes-associatedautoantibodies,nonobese, lacking other metabolic features especially with strong family…”
BackgroundMeijnikman, A. S., De Block, C. E. M., Dirinck, E., Verrijken, A., Mertens, I., Corthouts, B., & Van Gaal, L. F. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.165 · Cited by 112 · cited 1×
“Compared with FPG and A1C cut points, the 2-h PG value diagnoses more people with prediabetes and diabetes (15).”
BackgroundManagement of cystic fibrosis-related diabetes in children and adolescents
Moran, A., Pillay, K., Becker, D. J., & Acerini, C. L. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12178 · Cited by 112
Identifying Adults at High Risk for Diabetes and Cardiovascular Disease Using Hemoglobin A1c
Ackermann, R. T., Cheng, Y. J., Williamson, D. F., & Gregg, E. W. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.09.022 · Cited by 111 · cited 2×
“Other analyses suggest that A1C of 5.7% (39mmol/mol) or higher is associated with a diabetes risk similar to that of the high-risk participants in the Diabetes Prevention Program (DPP) (51), and A1C at baseline was a strong predictor of the development of glucose-defined diabetes during the DPP and its follow-up (52).”
BackgroundInfluentialYumei, W., Huixia, Y., Weiwei, Z., Hongyun, Y., Haixia, L., Jie, Y., & Cuilin, Z. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140898 · Cited by 109 · cited 1×
“Data comparing population-wide outcomes with one-step versus two-step approaches have been inconsistent to date (159,160).”
ResultThomas, M. C., Mathew, T. H., Russ, G. R., Rao, M. M., & Moran, J. (2001) · Transplantation · doi:10.1097/00007890-200110150-00024 · Cited by 108 · cited 1×
“Most studies have reported that transplant patients with hyperglycemia and PTDM after transplantation have higher rates of rejection, infection, and rehospitalization (89,91,96).”
BackgroundTrends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy
Jovanovič, L., Liang, Y., Weng, W., Hamilton, M., Chen, L., & Wintfeld, N. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2656 · Cited by 105
Feldman, R. K., Tieu, R. S., & Yasumura, L. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001132 · Cited by 105
Total Pancreatectomy With Islet Autotransplantation: Summary of an NIDDK Workshop
Bellin, M. D., Gelrud, A., Arreaza-Rubin, G., Dunn, T. B., Humar, A., Morgan, K. A., Naziruddin, B., Rastellini, C., Rickels, M. R., Schwarzenberg, S. J., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001059 · Cited by 98 · cited 1×
“In the context of pancreatectomy, islet autotransplantationcanbedonetoretain insulin secretion (123,124).”
BackgroundSelvin, E. (2016) · Diabetes Care · doi:10.2337/dc16-0042 · Cited by 96
Ethridge, J. K., Catalano, P. M., & Waters, T. P. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000412 · Cited by 95 · cited 1×
“In addition, pregnancies complicated by GDM per the IADPSG criteria, but not recognized as such, have outcomes comparable to pregnancies with diagnosed GDM by the morestringent two-stepcriteria (161,162).”
BackgroundPeng, T. Y., Ehrlich, S. F., Crites, Y., Kitzmiller, J. L., Kuzniewicz, M. W., Hedderson, M. M., & Ferrara, A. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.007 · Cited by 94
Pioglitazone in the Management of Diabetes Mellitus after Transplantation
Luther, P., & Baldwin, D. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00613.x · Cited by 91 · cited 1×
“Thiazolidinediones have been used successfully in patients with liver andkidney transplants, but side effects include fluid retention, heart failure, and osteopenia (98,99).”
BackgroundEmerging treatments for post-transplantation diabetes mellitus
Jenssen, T., & Hartmann, A. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.59 · Cited by 90
Strom Halden, T. A., Asberg, A., Vik, K., Hartmann, A., & Jenssen, T. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft536 · Cited by 89 · cited 1×
“Dipeptidyl peptidase 4 inhibitors do not interact with immunosuppressant drugs and have demonstrated safety in small clinical trials (100,101).”
BackgroundSharif, A., Moore, R. H., & Baboolal, K. (2006) · Transplantation · doi:10.1097/01.tp.0000250924.99855.42 · Cited by 88 · cited 10×
“No studies to date have established which noninsulin agents are safest or most efficacious in PTDM.”
MethodInfluentialHope, S. V., Wienand-Barnett, S., Shepherd, M., King, S. M., Fox, C., Khunti, K., Oram, R. A., Knight, B. A., Hattersley, A. T., Jones, A. G., et al. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x684961 · Cited by 87
A Global Perspective of Latent Autoimmune Diabetes in Adults
Mishra, R., Hodge, K. M., Cousminer, D. L., Leslie, R. D., & Grant, S. F. A. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.07.001 · Cited by 87
Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus
Khalafallah, A., Phuah, E., Al-Barazan, A. M., Nikakis, I., Radford, A., Clarkson, W., Trevett, C., Brain, T., Gebski, V., & Corbould, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011059 · Cited by 86
Management of pancreatogenic diabetes: challenges and solutions
Makuc, J. (2016) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s99701 · Cited by 84
Insulin and oral agents for managing cystic fibrosis-related diabetes
Onady, G. M., & Stolfi, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004730.pub4 · Cited by 83
Urbanová, J., Rypáčková, B., Procházková, Z., Kučera, P., Černá, M., Anděl, M., & Heneberg, P. (2014) · Diabetic Medicine · doi:10.1111/dme.12314 · Cited by 80
Sitagliptin Therapy in Kidney Transplant Recipients With New-Onset Diabetes After Transplantation
Lane, J. T., Odegaard, D. E., Haire, C. E., Collier, D. S., Wrenshall, L. E., & Stevens, R. B. (2011) · Transplantation · doi:10.1097/tp.0b013e3182347ea4 · Cited by 79
Screening for prediabetes and type 2 diabetes in dental offices
Herman, W. H., Taylor, G. W., Jacobson, J. J., Burke, R., & Brown, M. B. (2015) · Journal of Public Health Dentistry · doi:10.1111/jphd.12082 · Cited by 77 · cited 1×
“Because periodontal disease is associated with diabetes, the utility of screening in a dental setting and referral to primary care as a means to improve the diagnosis of prediabetes and diabetes has been explored (69–71), with one study estimating that 30% of patients $30 years of age seen in general dental practices…”
BackgroundCurrent state and future evolution of pancreatic islet transplantation
Anazawa, T., Okajima, H., Masui, T., & Uemoto, S. (2019) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12214 · Cited by 77 · cited 1×
“In the context of pancreatectomy, islet autotransplantationcanbedonetoretain insulin secretion (123,124).”
BackgroundNew insights into cystic fibrosis-related diabetes in children
Ode, K. L., & Moran, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70015-9 · Cited by 76 · cited 1×
“Continuous glucose monitoring or HOMA of b-cell function (79)maybemore sensitive thanOGTT to detect risk for progression to CFRD; however, evidence linking these results to long-term outcomes is lacking, and these tests are not recommended for screening (80).”
BackgroundKurian, B., Joshi, R., & Helmuth, A. (2008) · Endocrine Practice · doi:10.4158/ep.14.8.979 · Cited by 73 · cited 1×
“A small short-term pilot study reported that metformin was safe to use in renal transplant recipients (97), but its safety has not been determined in other types of organ transplant.”
BackgroundDental findings and identification of undiagnosed hyperglycemia
Lalla, E., Cheng, B., Kunzel, C., Burkett, S., & Lamster, I. B. (2013) · Journal of Dental Research · doi:10.1177/0022034513502791 · Cited by 73
Johnson, S. L., Tabaei, B. P., & Herman, W. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.307 · Cited by 73
Selvin, E., Wang, D., Matsushita, K., Grams, M. E., & Coresh, J. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0091 · Cited by 73
Gale, E. A. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0348-7 · Cited by 71 · cited 1×
“Future classification schemes for diabetes will likely focus on the pathophysiology of the underlying b-cell dysfunction (8,10,11).”
BackgroundComparison of screening scores for diabetes and prediabetes
Poltavskiy, E., Kim, D. J., & Bang, H. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.022 · Cited by 70
The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis
Duggan, S. N., Ewald, N., Kelleher, L., Griffin, O. M., Gibney, J., & Conlon, K. C. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.127 · Cited by 68
Herman, W. H. (2016) · Diabetes Care · doi:10.2337/dc15-2686 · Cited by 68
Buse, J. B., Kaufman, F. R., Linder, B., Hirst, K., El ghormli, L., Willi, S., & for the HEALTHY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-0295 · Cited by 67
Noctor, E., Crowe, C., Carmody, L. A., Saunders, J. A., Kirwan, B., O’Dea, A., Gillespie, P., Glynn, L. G., McGuire, B. E., O’Neill, C., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1260 · Cited by 65 · cited 1×
“GDM is often indicative of underlying b-cell dysfunction (135), which confers marked increased risk for later development of diabetes, generally but not always type 2 diabetes, in the mother after delivery (136,137).”
BackgroundGlycated Hemoglobin A 1c as Screening for Diabetes Mellitus in HIV-Infected Individuals
Eckhardt, B. J., Holzman, R. S., Kwan, C. K., Baghdadi, J., & Aberg, J. A. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0379 · Cited by 64
Early peri-operative hyperglycaemia and renal allograft rejection in patients withoutdiabetes
Thomas, M. C., Moran, J., Mathew, T. H., Russ, G. R., & Mohan Rao, M. (2000) · BMC Nephrology · doi:10.1186/1471-2369-1-1 · Cited by 60 · cited 2×
“In most cases, such stress- or steroidinduced hyperglycemia resolves by the time of discharge (89,90).”
BackgroundCommunity-based screening for diabetes in Michigan
Tabaei, B. P., Burke, R., Constance, A., Hare, J., May-Aldrich, G., Parker, S. A., Scott, A., Stys, A., Chickering, J., & Herman, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.668 · Cited by 56 · cited 1×
“, it may fail to reach the groups most at risk and inappropriately test those at very low risk or even those who have already been diagnosed (68).”
BackgroundHarper, L. M., Mele, L., Landon, M. B., Carpenter, M. W., Ramin, S. M., Reddy, U. M., Casey, B., Wapner, R. J., Varner, M. W., Thorp, J. M., et al. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001383 · Cited by 56
Quartuccio, M., Hall, E., Singh, V., Makary, M. A., Hirose, K., Desai, N., Walsh, C., Warren, D., Sun, Z., Stein, E., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2952 · Cited by 53 · cited 1×
“In others, it may decrease insulin requirements (125).”
BackgroundSelvin, E., Rawlings, A. M., Bergenstal, R. M., Coresh, J., & Brancati, F. L. (2013) · Diabetes Care · doi:10.2337/dc12-2715 · Cited by 51
Gilmour, J. A., Sykes, J., Etchells, E., & Tullis, E. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.04.008 · Cited by 51 · cited 2×
“8% in a second study) would detect more than 90% of cases and reduce patient screening burden (77,78).”
BackgroundHemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children
Drugs and Therapeutics Committee of the Pediatric Endocrine Society, Kapadia, C., & Zeitler, P. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-31 · Cited by 50
Diabetes Care After Transplant
Wallia, A., Illuri, V., & Molitch, M. E. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.01.005 · Cited by 50 · cited 12×
“No studies to date have established which noninsulin agents are safest or most efficacious in PTDM.”
BackgroundInfluentialJacobsen, L. M., Larsson, H. E., Tamura, R. N., Vehik, K., Clasen, J., Sosenko, J., Hagopian, W. A., She, J., Steck, A. K., Rewers, M., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12812 · Cited by 48 · cited 1×
“In The Environmental Determinants of Diabetes in the Young (TEDDY) study, type 1 diabetes developed in 21% of 363 subjects with at least one autoantibody at 3 years of age (46).”
BackgroundErickson, S. C., Le, L., Zakharyan, A., Stockl, K. M., Harada, A. S. M., Borson, S., Ramsey, S. D., & Curtis, B. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03842.x · Cited by 46
Huvinen, E., Koivusalo, S. B., Meinilä, J., Valkama, A., Tiitinen, A., Rönö, K., Stach-Lempinen, B., & Eriksson, J. G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02477 · Cited by 46 · cited 1×
“This definition facilitated a uniform strategy for detection and classification of GDM, but this definition has serious limitations (126).”
BackgroundWu, E.-L., Kazzi, N. G., & Lee, J. M. (2013) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.419 · Cited by 45
Kester, L. M., Hey, H., & Hannon, T. S. (2012) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2012.02.009 · Cited by 40 · cited 1×
“Although A1C is not recommended for diagnosis of diabetes in childrenwith cystic fibrosis or symptoms suggestive of acute onset of type 1 diabetes and only A1C assays without interference are appropriate for children with hemoglobinopathies, the ADA continues to recommend A1C for diagnosis of type 2 diabetes in this c…”
BackgroundMainguy, C., Bellon, G., Delaup, V., Ginoux, T., Kassai-Koupai, B., Mazur, S., Rabilloud, M., Remontet, L., & Reix, P. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0184 · Cited by 37
The usefulness of HbA1c in postpartum reclassification of gestational diabetes
Megia, A., Näf, S., Herranz, L., Serrat, N., Yañez, R., Simón, I., & Vendrell, J. (2012) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2012.03325.x · Cited by 36
Hutchins, J., Barajas, R. A., Hale, D., Escaname, E., & Lynch, J. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12463 · Cited by 36
Mission, J. F., Catov, J., Deihl, T. E., Feghali, M., & Scifres, C. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002277 · Cited by 36 · cited 1×
“Because of the number of pregnant women with undiagnosed type 2 diabetes, it is reasonable to test women with risk factors for type 2 diabetes (133) (Table 2.”
BackgroundAwa, W. L., Schober, E., Wiegand, S., Herwig, J., Meissner, T., Schmidt, F., Molz, E., & Holl, R. W. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.011 · Cited by 35 · cited 1×
“For individuals with MODY, the treatment implications are considerable and warrant genetic testing (104,105).”
BackgroundGöbl, C. S., Bozkurt, L., Yarragudi, R., Tura, A., Pacini, G., & Kautzky‐Willer, A. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0574-2 · Cited by 34
Humphreys, A., Bravis, V., Kaur, A., Walkey, H. C., Godsland, I. F., Misra, S., Johnston, D. G., & Oliver, N. S. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107789 · Cited by 28
HbA1c for type 2 diabetes diagnosis in Africans and African Americans: personalized medicine now
Paterson, A. D. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002384 · Cited by 26
Hyperglycemia management in patients with posttransplantation diabetes
Galindo, R. J., Fried, M., Breen, T., & Tamler, R. (2016) · Endocrine Practice · doi:10.4158/ep151039.ra · Cited by 25 · cited 10×
“No studies to date have established which noninsulin agents are safest or most efficacious in PTDM.”
BackgroundInfluentialThe association between glycemic control and clinical outcomes after kidney transplantation
Ramirez, S. C., Maaske, J., Kim, Y., Neagu, V., DeLange, S., Mazhari, A., Gao, W., Emanuele, M. A., Emanuele, N., Baldwin, D., et al. (2014) · Endocrine Practice · doi:10.4158/ep13463.or · Cited by 24
Gilmour, J. A. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.02.002 · Cited by 9 · cited 2×
“8% in a second study) would detect more than 90% of cases and reduce patient screening burden (77,78).”
Background
Research works printed but not linked: 2
- Dabelea, 2014, SEARCH for Diabetes in Youth Study Group. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for Diabetes in Youth Study, e938
- Araneta, 2014, Optimum BMI cut-points to screen Asian Americans for type 2 diabetes: The UCSD Filipino Health Study and the North Kohala Study [Abstract], A20
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-12-16
- Volume
- 43
- Issue
- Supplement_1
- Pages
- S14-S31
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4235479662
- Cited by
- 3,187
- References
- 159
- Citations by year
- 2026: 158 · 2025: 302 · 2024: 424 · 2023: 459 · 2022: 705 · 2021: 757 · 2020: 380 · 2019: 1
- FWCI
- 373.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes classification, diabetes diagnosis, diabetes diagnosis criteria, diabetes subtypes, clinical guidelines, quality of care evaluation
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, United States, History, 21st Century, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.